Futures Surge as Pfizer, BioNTech Vaccine Candidates Receive FDA Fast Track Status

July 13, 2020
Futures rise as Pfizer and BioNTech receive FDA fast track status for two coronavirus vaccine candidates. Matt Orton, Vice President & Portfolio Specialist at Carillon Tower Advisers, joined Wake Up With Cheddar to talk more about how this is driving the markets.
We use cookies and similar technologies on this site to collect identifiers, such as IP address, and cookie and device IDs as described in our Privacy Policy.